Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

NeuroBo Pharmaceuticals Reports Top-Line Results From Part 1 Of Phase 1 Trial For DA-1726 In Obesity Treatment, Showing Favorable Safety And Dose-Linear Pharmacokinetics, With Part 2 Data Expected Q1 2025

Author: Benzinga Newsdesk | September 30, 2024 08:04am

Posted In: NRBO